Background/Aims Percutaneous kidney biopsy (PKB) may be the principal diagnostic tool for kidney disease. and loss of life in 0.1 and 0.15% of IO and ODS patients, respectively. Outcomes ODS costs USD 1,394 per biopsy in comparison to USD 1,800 for IO including all problems. IC for ODS stay less when general complications